RESTORATION OF OESTROGEN POSITIVE FEEDBACK EFFECT ON LH RELEASE BY BROMOCRIPTINE IN HYPERPROLACTINAEMIC PATIENTS WITH GALACTORRHOEA-AMENORRHOEA

• Published in: Acta endocrinologica (Copenhagen) Vol. 91; no. 3; pp. 591 - 600
• Main Authors: Aono, T, Miyake, A, Yasuda, T S, Koike, K, Kurachi, K
• Format: Journal Article
• Language: English
• Published: Denmark 01.07.1979
• Subjects: Adult; Amenorrhea - blood; Amenorrhea - drug therapy; Amenorrhea - physiopathology; Bromocriptine - therapeutic use; Estradiol - blood; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone - blood; Follicle Stimulating Hormone - metabolism; Galactorrhea - blood; Galactorrhea - drug therapy; Galactorrhea - physiopathology; Gonadotropin-Releasing Hormone; Humans; Lactation Disorders - drug therapy; Luteinizing Hormone - blood; Luteinizing Hormone - metabolism; PITUITARY; Pregnancy; Prolactin - blood
• ISSN: 0804-4643; 0001-5598; 1479-683X
• DOI: 10.1530/acta.0.0910591

ABSTRACT Five mg of bromocriptine was administered for 3 weeks to 8 hyperprolactinaemic women with galactorrhoea-amernorrhoea, in whom the response of serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to 100 μg of iv LH-releasing hormone (LH-RH) had been evaluated. Twenty mg of conjugated oestrogen (Premarin®) was injected iv any day between the 10th and 12th day from the initiation of the treatment, and serum LH levels were serially determined for 120 h. Hyperresponse of LH with normal FSH response to LH-RH was observed in most patients. Bromocriptine treatment for 10 to 12 days significantly suppressed mean (± se) serum prolactin (PRL) levels from 65.1 ± 23.0 to 10.4 ± 2.0 ng/ml, while LH (12.6 ± 2.1 to 24.8 ± 5.9 mIU/ml) and oestradiol (40.1 ± 7.6 to 111.4 ± 20.8 pg/ml) levels increased significantly. Patients on bromocriptine treatment showed LH release with a peak at 48 h after the injection of Premarin. The mean per cent increases in LH were significantly higher than those in untreated patients with galactorrhoea-amenorrhoea between 32 and 96 h after the injection. The present results seem to suggest that the restoration of LH-releasing response to oestrogen following suppression of PRL by bromocriptine may play an important role in induction of ovulation in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.